Tick-borne anaplasmosis on the rise in Canada, CMAJ study warns
Blacklegged ticks are becoming more common from Manitoba eastwards, particularly in Ontario, Quebec and Nova Scotia
Doctors are being urged to consider anaplasmosis alongside Lyme disease when treating patients with unexplained fever, as tick-borne illnesses continue to rise across eastern Canada.
A paper published in the Canadian Medical Association Journal (CMAJ) highlights the case of a 79-year-old man from eastern Ontario who developed fever, chills and weakness after likely exposure to blacklegged ticks.
He recovered after receiving the antibiotic doxycycline, with laboratory tests later confirming anaplasmosis.
“It’s really important to be talking about this infection because we’re observing it more and more in clinical practice, in internal medicine, and it’s new,” senior author Dr Michael Quon said in an interview.
“This is not an infection that we encountered even five years ago in the hospital.”
According to the Public Health Agency of Canada, blacklegged ticks are becoming more common from Manitoba eastwards, particularly in Ontario, Quebec and Nova Scotia.
Officials say infections with the bacteria that causes anaplasmosis are also increasing.
Doctors are advised to ask patients about outdoor exposure and begin treatment promptly if anaplasmosis is suspected, rather than waiting for laboratory confirmation.
Health experts say people should continue enjoying outdoor activities while taking precautions, including using insect repellent, wearing protective clothing and checking for ticks after spending time in wooded or grassy areas.
Removing ticks quickly can significantly reduce the risk of infection.
-
'Self-exercising' muscle implants developed by researchers offer workout benefits without movement
-
GLP-1 drugs cut US obesity from 39.9% to 36.4%
-
New clinical trial highlights precision-dosing strategy for vitamin D deficiency management
-
Cyclospora outbreak: USDA research projects shelved amid funding cuts and relocations
-
AI tool flags severe heart failure with 91% sensitivity
-
Xylitol sweetener may raise stroke and heart attack risks, study suggests
-
US FDA approves Mounjaro to reduce cardiovascular risk
-
New discovery reveals how the brain could turn off chronic pain